Back to Authors

Morales, M.

Mayo Clinic

Seattle Children's Hospital

Citations 3

Acute and Long‐Term EEG and seizure characteristics in new onset refractory status epilepticus (NORSE)
Gilani, Kia , Hanin, Aurélie , Gaspard, Nicolas , Batra, Ayush , Behrndt, Laken, Day, Gregory S. , Demeret, Sophie , Eschbach, Krista , Foreman, Brandon , Gerard, Elizabeth E. , Gopaul, Margaret T., Hantus, Stephen , Cobos‐Hernandez, Carla, Jimenez, Anthony D. , Jongeling, Amy, Kandula, Padmaja , Kang, Peter, Kellogg, Marissa, Kim, Minjee , Farias‐Moeller, Raquel , Morales, M., Pimentel, Cederic M., Ramírez, Alexandra , Taraschenko, Olga , Zhou, Daniel J., Gofton, Teneille E , Haider, Hiba A , Kandula, Padmaja , Farias-Moeller, Raquel , Navarro, Vincent , Steriade, Claude , Struck, A F , Taraschenko, Olga , Wainwright, Mark S , Hirsch, Lawrence J , Yoo, Ji Yeoun , Eschbach, Krista , Gaspard, Nicolas , Day, Gregory S , Batra, Ayush , Hanin, Aurelie , Foreman, Brandon , Gerard, Elizabeth E , Kim, Minjee , Gofton, Teneille , Gopaul, Margaret , Haider, Hiba A. , Jongeling, Amy , Kazazian, Karnig , Kellogg, Marissa , Navarro, Vincent , Steriade, Claude , Struck, Aaron F. , Wainwright, Mark S. , Zhou, Daniel J., Hirsch, Lawrence J. , Yoo, Ji Yeoun

Epilepsia | June 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/epi.70349 Get It

Abstract Objective This study was undertaken to examine acute and chronic electroencephalographic (EEG) and seizure characteristics in new onset refractory status epilepticus (NORSE). Methods Multicenter inpatient and follow‐up clinical and EEG data were analyzed using International League Against Epilepsy definitions and American Clinical Neurophysiology Society (ACNS) EEG terminology. Results Forty‐four patients were included from the Yale NORSE/FIRES Biorepository (median age = 29 years, 33 female, 38 cryptogenic). Nine hundred twenty inpatient EEG days were reviewed (median = 13.5 days/patient). Presenting status epilepticus (SE) types included 24 convulsive SE (CSE), five focal–motor (FMSE), and 15 nonconvulsive (NCSE). Of 39 patients with post discharge follow‐up (median = 14.7 months), 61.5% ( n = 24) had seizures and required more antiseizure medications than seizure‐free patients (median = 4 vs. 1, p < .001). Inpatient EEG captured epileptiform discharges in all and periodic discharges in 38 patients. Seizures were captured in 38 patients: 33 electrographic (11 only electrographic) and 27 electroclinical. Total seizure burden ranged 6.5–29 615.0 min (median = 50.7). Seizures fulfilling ACNS EEG criteria for SE were captured in 20 patients; two had CSE and the remainder NCSE with coma, nine of whom also had FMSE. Inpatient seizure days (median = 50.0 vs. 15.5%, p = .004) and seizure burden (median = 42.9 vs. 0 min, p = .009) were higher in the first half of monitored days. Interictal findings were equally present and did not predict postdischarge seizures, whereas electroclinical seizures (90.9% vs. 45.5%, p = .037), seizure burden (median = 116.8 vs. 32.5 min, p = .045), and proportion of seizure days (36.3% vs. 20.0%, p = .037) did. Among 12 patients with follow‐up EEGs (median = 19.6 months post onset), posterior‐dominant rhythm (PDR) returned in nine; five had periodic discharges, and three had seizure captured. Significance Seizures are most commonly convulsive upon presentation and nonconvulsive or clinically subtle throughout the inpatient course in NORSE. Inpatient seizures, but not interictal abnormalities, occur earlier in the inpatient course and presence of electroclinical seizures, seizure burden, and proportion of seizure days but not interictal findings are associated with postdischarge seizures. Although return of PDR reflects neurological recovery, seizure persistence and EEG abnormalities post‐NORSE are common.
Quality of life over time after new onset refractory status epilepticus
Gruen, Matthew D. , Jimenez, Anthony D. , Batra, Ayush , Blank, Leah J. , Damien, Charlotte , Day, Gregory S. , Eschbach, Krista , Gofton, Teneille , Hantus, Stephen , Kang, Peter , Kim, Minjee , Madani, Bahar, Morales, M., Punia, Vineet , Taraschenko, Olga , Torcida, Nathan , Wainwright, Mark S. , Yoo, Ji Yeoun , Wong, Nora , Batra, Ayush , Blank, Leah J , Damien, Charlotte , Eschbach, Krista , Gofton, Teneille E , Jette, Nathalie , Punia, Vineet , Taraschenko, Olga , Yoo, Ji Yeoun , Hirsch, Lawrence J , Hanin, Aurelie , Wainwright, Mark S , Day, Gregory S , Kim, Minjee , Gopaul, Margaret , Gerard, Elizabeth E. , Jetté, Nathalie , Jongeling, Amy , Kazazian, Karnig , Kellogg, Marissa , Steriade, Claude , Struck, Aaron F. , Gaspard, Nicolas , Wong, Nora, Hirsch, Lawrence J. , Hanin, Aurélie

Epilepsia | September 13, 2025 | Volume: 67 | Issue: 1 | Pages: 328-340

10.1111/epi.18635 Get It

Abstract Objective This study aims to better characterize the long‐term neurological quality of life (QOL) outcomes (using the Neuro‐QOL scale) in survivors of new onset refractory status epilepticus (NORSE), including its subtype febrile infection‐related epilepsy syndrome (FIRES), and provide guidance for psychological and social support strategies. Methods Utilizing data from a multicenter prospective study of NORSE/FIRES led by Yale University, we enrolled patients who completed the validated, patient‐reported Neuro‐QOL scale at least once at 3–6 months ( n = 37), 12 months ( n = 29), 24 months ( n = 23), or ≥36 months ( n = 9) following discharge. The Neuro‐QOL scale assesses physical, mental, and social health in patients with neurological disorders. QOL impairment (QOL‐I) scores were calculated, with higher scores indicating greater impairment. T ‐scores enabled comparisons with reference populations. Results In adults, median QOL‐I improved from 44.1% at 3–6 months to 37.6% at 36+ months. Paired analysis showed significant improvement in QOL‐I between 3–6 and 24 months ( p = .016), with specific improvements in communication, satisfaction with social roles, fatigue, and mobility. Greater improvement was also observed for participation in social roles (5.5‐point T ‐score gain) compared to the reference population, suggesting meaningful change. A gradual improvement in overall QOL‐I scores was also observed in pediatric participants, despite a modest sample size ( n = 5 with data at 3–6 and 12 months). Measures of fatigue and anxiety persisted in adults, and cognitive difficulties persisted in both adults and children. In adults, longer status epilepticus duration and intensive care unit stay were associated with poorer QOL. Additionally, a higher number of antiseizure medications was associated with more depression, cognitive impairments, and perceived stigma. Significance These findings highlight the potential for recovery following an acute episode of NORSE, although many patients continue to face challenges requiring ongoing support, and the clinical meaning of the reported QOL improvement remains unclear. Furthermore, the findings underscore the importance of strategic multidisciplinary support systems in the years following discharge.